Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Berti, M; Ray Chaudhuri, A; Thangavel, S; Gomathinayagam, S; Kenig, S; Vujanovic, M; Odreman, F; Glatter, T; Graziano, S; Mendoza-Maldonado, R; Marino, F; Lucic, B; Biasin, V; Gstaiger, M; Aebersold, R; Sidorova, JM; Monnat, RJ; Lopes, M; Vindigni, A.
Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition.
Nat Struct Mol Biol. 2013; 20(3): 347-354.
Doi: 10.1038/nsmb.2501
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Biasin Valentina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Topoisomerase I (TOP1) inhibitors are an important class of anticancer drugs. The cytotoxicity of TOP1 inhibitors can be modulated by replication fork reversal through a process that requires poly(ADP-ribose) polymerase (PARP) activity. Whether regressed forks can efficiently restart and what factors are required to restart fork progression after fork reversal are still unknown. We have combined biochemical and EM approaches with single-molecule DNA fiber analysis to identify a key role for human RECQ1 helicase in replication fork restart after TOP1 inhibition that is not shared by other human RecQ proteins. We show that the poly(ADP-ribosyl)ation activity of PARP1 stabilizes forks in the regressed state by limiting their restart by RECQ1. These studies provide new mechanistic insights into the roles of RECQ1 and PARP in DNA replication and offer molecular perspectives to potentiate chemotherapeutic regimens based on TOP1 inhibition.
- Find related publications in this database (using NLM MeSH Indexing)
-
Camptothecin - pharmacology
-
Cell Line -
-
DNA Replication -
-
DNA Topoisomerases, Type I - metabolism
-
Humans -
-
Poly (ADP-Ribose) Polymerase-1 -
-
Poly(ADP-ribose) Polymerases - genetics
-
Poly(ADP-ribose) Polymerases - metabolism
-
RecQ Helicases - genetics
-
RecQ Helicases - metabolism
-
Topoisomerase I Inhibitors - pharmacology